FENTANYL OVERDOSE SYMPTOMS AND DURATION SECRETS

Coadministration of pexidartinib (a CYP3A4 inducer) with sensitive CYP3A substrates may possibly result in critical therapeutic failures. If concomitant use is unavoidable, enhance the CYP3A substrate dosage in accordance with accepted solution labeling.If coadministration of CYP3A4 inhibitors with fentanyl is necessary, check patients for respirat